Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in OBIO — Orchestra BioMed Holdings, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in OBIO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$414,464
-$229,325 QoQ
Shares Held
97,521
-37.1% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
7 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in OBIO Over Time

Shares Held

Position Value (USD)

Derivatives in OBIO

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
0
PutValue
$149,048
PutShares
60,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. OBIO ranks #249 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OBIO

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $414,464 97,521
2025-12-31 $643,789 155,130
2025-09-30 $149,048 60,100
2025-09-30 $243,300 98,105
2025-06-30 $317,735 118,558
2025-03-31 $141,188 32,988
2024-12-31 $48,676 12,169
2023-09-30 $110,281 12,647